Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders
US5200405A · kind A · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 1991 |
| Grant date | Apr 6, 1993 |
| Priority date | — |
| Expiry date | Sep 11, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and n are as defined in the description, for the treatment of cholinergic transmission disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.